menu
    • menu

    Company profile for Catamaran Bio

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Catamaran brings together leading-edge scientific founders and experts in NK cells, synthetic biology, manufacturing and clinical cell therapy with an internal team which has deep expertise developing cell therapies. We are supported by a broad syndicate of leading life science investors that is committed to developing innovative cell therapies. Catamaran has developed the TAILWIND™ Platform, a proprietary and integrated su...
    Catamaran brings together leading-edge scientific founders and experts in NK cells, synthetic biology, manufacturing and clinical cell therapy with an internal team which has deep expertise developing cell therapies. We are supported by a broad syndicate of leading life science investors that is committed to developing innovative cell therapies. Catamaran has developed the TAILWIND™ Platform, a proprietary and integrated suite of technologies, to engineer, expand and process NK cells into safe and effective, off-the-shelf cell therapy products for multiple cancer types.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Catamaran BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    610 Main Street Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://catamaranbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/catamaran-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Catamaran Announces Data from Allogeneic CAR-NK Cell Therapy Pipeline
    Catamaran Announces Data from Allogeneic CAR-NK Cell Therapy Pipeline

    11 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/11/2644346/0/en/Catamaran-Bio-Announces-Preclinical-Data-from-Allogeneic-CAR-NK-Cell-Therapy-Pipeline-for-Solid-Tumors-to-be-Presented-at-the-American-Association-for-Cancer-Research-AACR-Annual-M.html

    GLOBENEWSWIRE
    11 Apr 2023
    Share Share
    Catamaran Bio, OmniaBio Partner to Advance Allogeneic CAR-NK Cell Therapies
    Catamaran Bio, OmniaBio Partner to Advance Allogeneic CAR-NK Cell Therapies

    14 Mar 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-14/catamaran-bio-omniabio-partner-to-advance-allogeneic-car-nk-cell-therapies/?widget=listSection

    CONTRACT PHARMA
    14 Mar 2023
    Share Share
    Catamaran Bio selects OmniaBio as partner to develop CAR-NK cell therapies
    Catamaran Bio selects OmniaBio as partner to develop CAR-NK cell therapies

    14 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230314005418/en

    BUSINESSWIRE
    14 Mar 2023
    Share Share
    MaxCyte Signs Strategic Platform License with Catamaran Bio t
    MaxCyte Signs Strategic Platform License with Catamaran Bio t

    03 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/01/03/2582484/0/en/MaxCyte-Signs-Strategic-Platform-License-with-Catamaran-Bio-to-Support-its-CAR-NK-Cell-Therapy-Programs.html

    GLOBENEWSWIRE
    03 Jan 2023
    Share Share
    Catamaran Bio Preclinical Efficacy Data for Two Allogeneic CAR-NK Cell Therapies
    Catamaran Bio Preclinical Efficacy Data for Two Allogeneic CAR-NK Cell Therapies

    10 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221110005036/en

    BUSINESSWIRE
    10 Nov 2022
    Share Share
    Catamaran SI Joint System Receives Review Board Approval for Post Market Studies
    Catamaran SI Joint System Receives Review Board Approval for Post Market Studies

    25 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/721803/Tenon-Medicals-CatamaranTM-SI-Joint-Fusion-System-Receives-Institutional-Review-Board-Approval-for-Two-Strategic-Post-Market-Studies

    ACCESSWIRE
    25 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search